MJH Associates has acquired UBM Life Sciences’ healthcare media assets from Informa
MJH Associates‚ Inc. (MJH) has acquired major market media assets from the UBM Life Sciences Group of Informa PLC (INF.L). The transaction consideration was in excess of US$100 million.
MJH is the largest privately held, independent full-service medical media company in the US dedicated to delivering trusted healthcare news across multiple channels. Over 600 MJH associates are dedicated to providing healthcare professionals with the information and resources they need to optimize patient outcomes. MJH combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies.
The acquisition of UBM Life Sciences Group assets includes iconic multimedia platforms in the healthcare, animal care, pharma sciences and dental fields as well as three preeminent veterinarian conferences.
Informa is a leading international exhibitions, events, information services and scholarly research group with annual revenues approaching US$4 billion. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and provide opportunities to connect and learn.
One of Oaklins’ TMT specialist teams in New York acted as the exclusive M&A advisor to MJH Associates in this transaction.
Michael J. Hennessy Jr.
President, MJH Associates, Inc.
Talk to the deal team
Roland DeSilva
Oaklins DeSilva+Phillips
Related deals
Skynamo has been acquired by Klipboard
Klipboard, a global provider of vertical business management software, has completed the acquisition of Skynamo, a market-leading mobile field sales platform used by manufacturers, wholesalers and distributors worldwide. The acquisition adds Skynamo’s award-winning field sales platform to Klipboard’s portfolio and enhances its ability to support wholesalers, distributors and retailers in managing complex operations across many industries.
Learn moreInstituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreGroupe JVS has acquired Abelium Collectivités
Groupe JVS has acquired Abelium Collectivités, which was subsequently rebranded as Familea. The transaction, supported by CAPZA as a minority shareholder and Bpifrance, strengthens Groupe JVS’s strategy in the childcare and family services sector while expanding its offering to local public sector stakeholders.
Learn more